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a b s t r a c t
We present a comparative study of several non-covalent approaches to disperse, debundle and non-
covalently functionalize double-walled carbon nanotubes (DWNTs). We investigated the ability of
bovine serum albumin (BSA), phospholipids grafted onto amine-terminated polyethylene glycol (PL-
PEG2000-NH2), as well as a combination thereof, to coat purified DWNTs. Topographical imaging with
the atomic force microscope (AFM) was used to assess the coating of individual DWNTs and the degree
of debundling and dispersion. Topographical images showed that functionalized DWNTs are better
separated and less aggregated than pristine DWNTs and that the different coating methods differ in
their abilities to successfully debundle and disperse DWNTs. Height profiles indicated an increase in the
diameter of DWNTs depending on the functionalization method and revealed adsorption of single
molecules onto the nanotubes. Biofunctionalization of the DWNT surface was achieved by coating
DWNTs with biotinylated BSA, providing for biospecific binding of streptavidin in a simple incubation
step. Finally, biotin-BSA-functionalized DWNTs were immobilized on an avidin layer via the specific
avidin–biotin interaction.
1. Introduction
Due to their remarkable electronic, mechanical, chemical and
thermal properties CNTs have turned out to be nanodevices with a
wide range of potential applications in various composite
materials, technical devices [1,2], as well as medical and
pharmaceutical products [3,4]. Double-walled carbon nanotubes
(DWNTs) are of special interest as they bridge the gap between
single-walled carbon nanotubes (SWNTs) and the more complex
multi-walled carbon nanotubes (MWNTs). DWNTs are comparable
to SWNTs with respect to their small diameter, yet their
mechanical stability is much higher than that of SWNTs. More-
over, the outer wall can be functionalized without changing the
mechanical and electronic properties of the inner nanotube [5].
These properties make them attractive for biological and
biomedical applications. However, DWNTs, as all pristine CNTs,
have a strong tendency to aggregate and are practically insoluble
in any kind of solvent because of substantial van der Waals
attractions among them. Solubility in aqueous media, however, is
a fundamental prerequisite for potential biological and biomedical
applications. Several strategies have been explored to disperse
and solubilize CNTs which can be divided into two main
categories. One approach is based on covalent CNT functionaliza-
tion by cutting and oxidizing CNTs. Thus, carboxylic groups are
generated which are subsequently derivatized with different
types of molecules [6–10]. The second dispersal method is the
non-covalent coating of CNTs [11] with surfactants molecules
[12–14], nucleic acids [15–17], proteins and peptides [18–21], or
polymers [22–27]. The non-covalent dispersion procedures usual-
ly involve ultrasonication, centrifugation and filtration. They are
quick and easy, achieving debundling of CNTs, dispersion in water
and biocompatibility in one step.
In this study we present a comparative investigation of non-
covalent approaches to debundle, disperse and functionalize
DWNTs. We used bovine serum albumin (BSA) and a phospholi-
pid-linked polyethylene glycol chain with a terminal amino group
(PL-PEG-NH2), as well as a combination thereof, to coat purified
DWNTs. Topographical atomic force microscope (AFM) imaging
was used for the direct assessment of a successful functionaliza-
tion procedure and proved that functionalized DWNTs are better
separated and less aggregated than pristine DWNTs. We demon-
strate the ability of the non-covalent functionalization scheme to
provide DWNTs for specific recognition by, and binding of
biomolecules, using the well-studied biotin/avidin and biotin/
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streptavidin interaction [28]. We present high-resolution topo-
graphical images of functionalized DWNTs captured onto a
dense avidin layer in aqueous buffer solution. To our knowledge,
this is the first successful attempt to image single functionalized
carbon nanotubes in liquid under physiological conditions using
AFM.
2. Materials and methods
2.1. Preparation and purification of double-walled carbon nanotubes
Synthesis and purification of double-walled carbon nanotubes
used for the experiments are explained in detail elsewhere [5].
Briefly, DWNTs were synthesised by catalytic chemical vapour
deposition (CCVD), the catalyst being an Mg1xCoxO solid solution
containing added Mo oxide. The MgO-based catalyst was
removed by thorough washing with HCl solution. The extracted
powder contained only clean carbon nanotubes of which 80%
are DWNTs and the rest being SWNTs (15%) and triple-walled
CNTs (5%). HRTEM observation showed a variation of
outer diameter from 1.2 to 3.2 nm. The median outer diameter is
2.0 nm.
2.2. Non-covalent functionalization of DWNTs with BSA
Purified DWNTs and BSA (Roche) were mixed with ultra-pure
water with a concentration of 0.25 and 1.0mg/ml, respectively.
The mixture was sonicated for 45min (Bandelin Sonoplus GM70
at 20% power) under cooling in an ice bath. The procedure
resulted in a stable black suspension. The DWNT BSA suspension
was then filtered in centrifugation cartridges with ultrafiltration
membranes (nanosep, 300 kD cutoff) at around 5500g (Eppendorf
Centrifuge 5417C) and washed 5 times with ultra-pure water to
remove excess BSA. After re-suspension in ultra-pure water the
concentration of DWNTs was estimated to be 0.05–0.1mg/ml
due to loss of material at the sidewall of the filtration device and
the filter membrane. The suspension was stored at 4 1C until
further usage within the next 2–3 days.
2.3. Phospholipids (PL) grafted on polyethylene glycol (PEG)
PL-PEG-NH2 (2-distearoyl-sn-glycero-3-phosphoethanola-
mine-N-[amin(PEG)2000], Avanti Polar Lipids) was used at a
concentration of 1mg/ml to suspend DWNTs at a concentration of
0.25mg/ml in water using a similar sonication, filtration and
washing procedure as described for BSA coating. The speed of the
centrifuge was adjusted to 7000g for filtration and washing. The
ARTICLE IN PRESS
Fig. 1. Non-functionalized DWNTs. (a) Topographical image of DWNTs deposited on mica after immersion in 1,2-dichloroethane. The length of bundles varied between
several 100nm and 20mm. (b) Height profile along the white line in (a). (c) Cross-section profile along a pristine CNT. Arrows mark corresponding positions in (a). (d) Height
distribution of non-functionalized DWNTs.
final PL-PEG/DWNT suspension had an estimated concentration of
around 0.2mg/ml due to loss of material in the filter device.
2.4. Conjugation of BSA and PL-PEG to DWNTs
Purified DWNTs were added to a 5mM aqueous solution of BSA
at a final concentration of 0.25mg/ml and sonicated under cooling
for 45min. Subsequently, PL-PEG-NH2 was added to the suspen-
sion at a concentration of 0.5mg/ml. The mixture was sonicated
for an additional period of 45min under cooling. The suspension
was filtered by centrifugation through an ultrafiltration mem-
brane (300 kD cutoff) at 7000g to remove excess BSA and PEG-
lipids. The BSA and PL-PEG DWNT conjugates were washed and
re-suspended in ultra-pure water at a final concentration of
around 0.2mg/ml and stored at 4 1C.
2.5. Biotinylated BSA
Biotin-IgG was prepared similarly as described by Kamruzza-
han et al. [28]. 5mg (33nmol) goat IgG purchased from Sigmawas
dissolved in 0.5ml buffer (100mM NaCl, 35mM boric acid, pH
adjusted to 8.5 using NaOH) and 5ml of 66mM biotin-cap-NHS
[29] in DMSO were slowly added while gentle vortexing. After
30min reaction time (with occasional gentle vortexing) the
biotinylated IgG was purified using gel filtration [26]. The
functionalization of DWNTs with biotinylated BSA was done using
the same procedure as described above for BSA/DWNTs. The
filtered and washed functionalized DWNTs were re-suspended
either in ultra-pure water or in 0.1 PBS, a 9/1 mixture (v/v) of
water and phosphate-buffered saline (PBS, 150mM NaCl, 5mM
NaH2PO4, pH ¼ 7.4 adjusted with NaOH).
2.6. Incubation of biotin-BSA/DWNTs with streptavidin
Thirty microlitres of streptavidin with a concentration of
1.3mg/ml was added to 3.5ml aqueous suspension of biotin-
BSA-functionalized DWNTs at a concentration of around 0.2mg/
ml. The mixture was filtered and washed after 1 h of incubation
(nanosep, 300 kD cutoff) to remove excess streptavidin. The
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Fig. 2. Topographical images of BSA-coated DWNTs on mica obtained by contact mode imaging in air. (a) Survey scan showing mostly single and well-separated DWNTs. (b)
and (c) Images of individual DWNTs with bright dot-like structures potentially representing single BSA molecules. White arrows mark corresponding positions in the cross-
section profiles below.
remaining functionalized nanotubes were re-suspended in ultra-
pure water and stored at 4 1C.
2.7. Preparation of avidin layer and incubation with biotin-BSA/
DWNTs
In order to prepare a dense layer of avidin molecules for
incubation with biotin-BSA-functionalized DWNTs, a stock solu-
tion of avidin (1mg/ml in PBS) was diluted with 9 volumes of
water to adjust a final avidin concentration of 0.1mg/ml. Freshly
cleaved muscovite mica was mounted in a commercial AFM fluid
cell prior to AFM imaging and incubated with the diluted avidin
solution. The avidin molecules are immobilized onto mica via
electrostatic adsorption due to their positive net charge [26]. After
20min the mica sheet was extensively rinsed with 0.1 PBS.
Finally, the fluid cell was filled with 600ml of a biotin-BSA/DWNTs
suspension in 0.1 PBS at a concentration of 0.2mg/ml. The fluid
cell was allowed to stand for 20min. Before starting AFM imaging
the biotin-BSA/DWNTs suspension was removed and exchanged
for 0.1PBS.
2.8. Contact mode AFM imaging
For atomic force microscope imaging of purified DWNTs, a
small amount of the powdered sample was dispersed in 1,2-
dichloroethane (DCE) under strong sonication (Bandelin Sonoplus
GM70 at 50% power) in 3 cycles with 30 s sonication time each.
A 10ml droplet was placed on freshly cleaved mica substrate
immediately after sonication. For topographical imaging of bio-
molecule conjugated DWNTs samples were prepared by placing a
5–10ml droplet on freshly cleaved mica substrate and allowing it
to dry. Imaging was done with a Nanoscope IIIa (Digital
Instruments, Santa Barbara, CA) or a PicoSPM setup (Agilent
Technologies, Chandler, AZ) operated in contact mode at room
temperature with a lateral scan rate of 1–1.5Hz at 512 lines. AFM
cantilevers with a nominal spring constant of 0.01–0.03N/m were
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Fig. 3. Topographical images of DWNTs covered with PL-PEG2000-NH2. (a) Overview scan showing well-separated and individual DWNTs. (b) and (c) Images and cross-
section profiles of individual PL-PEG-coated DWNTs. Arrows mark positions in the corresponding cross-section profile. Arrows with numbers refer to corresponding
profiles.
used. Each functionalization procedure was repeated 2–4 times
and at least 2 samples were taken for AFM evaluation.
2.9. MAC mode imaging
Topographical imaging of biotin-BSA/DWNTs incubated on an
avidin layer was carried out in PBS at room temperature. Images
were acquired with a magnetically driven dynamic force micro-
scope (MACmode, Agilent Technologies, Chandler, AZ) equipped
with a conventional fluid cell. AFM tips with magnetic coating
(Agilent Technologies, Chandler, AZ) and nominal spring constant
of 0.1N/m were used. The measurement frequency was set to 20%
below the resonance frequency. Scanning was done with the
feedback adjusted to 40% amplitude reduction at a lateral scan
frequency of 1.0Hz with 512 scan lines per image.
3. Results and discussion
3.1. Topographical imaging of functionalized DWNTs
Fig. 1a shows a survey image of non-functionalized DWNTs
after immersion in the organic solvent DCE and subsequent
evaporation revealing aggregates and long bundles of different
height and length. Cross-sectional analysis (Fig. 1b and d) revealed
that most DWNTs are present as bundles ranging from 2 to
130nm in height and few micrometers in length. From cross-
section profiles taken on non-functionalized DWNTs the height
variance was observed to be 0.5 nm (Fig. 1c). Because of their
hydrophobic nature, many individual DWNTs aggregate and form
rope-like structures when the organic solvent is evaporated
[30–32].
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Fig. 4. Topographical images of bi-conjugated DWNTs using BSA and PL-PEG2000-NH2. (a) Overview scan. (b) and (c) Small scan size images with corresponding cross-
section profiles. Peaks in the cross-section profile suggest the adsorption of BSAwhile flat and amorphous segments indicate adsorption of PL-PEG2000-NH2. White arrows in
the images mark the positions where cross-section profiles were acquired.
Topographical images of an aqueous dispersion of BSA–DWNTs
are shown in Fig. 2. In contrast to un-modified DWNTs, the
majority of BSA–DWNTs were found to be well dispersed as
separated individual tubes (Fig. 2a). Bright dot-like structures
covering individual DWNTs were observed (Fig. 2b and c). From
the cross-section profiles along the tubes peak heights of 1–2nm
were obtained, suggesting the adsorption of single BSA molecules,
whereas peaks of up to 5nm in height indicated BSA multimers
attached to DWNTs. Recent studies on the adsorption of BSA and
HSA on carbon nanotubes showed that the adsorption is driven by
hydrophobic and electrostatic interactions [33,34].
Fig. 3a shows an overview scan of an aqueous dispersion of PL-
PEG-modified DWNTs (phospholipids grafted on polyethylene
glycol) with well-separated and mostly individual nanotubes.
Small scan size images (Fig. 3b and c) reveal that DWNTs
are uniformly wrapped with PL-PEG along the entire length of
the nanotube. The average height of PL-PEG-functionalized
DWNTs is 3nm, with peak heights of 6nm (Fig. 3b, lower
panel). In Fig. 3c the height profiles of three different tubes are
compared with step sizes of 1nm, which is the expected
thickness of PL-PEG coating.
Fig. 4 shows DWNTs dispersed with both BSA and PL-PEG
(DSPE-PEG2000-NH2). Again, short and individual DWNTs ap-
peared well separated. In small scan size images (Fig. 4b and c)
BSA was observed as dot-like structures on the nanotube surface
but was found not to cover the entire DWNT. Also, segments with
uniform and soft appearing features were visible on the DWNTs
suggesting the adsorption of PL-PEG. The immobilization of both
BSA and PL-PEG on the same DWNT indicates a bi-conjugation of
DWNT with BSA and PEG grafted phospholipids. The cross-section
profile indeed showed segments with distinct peaks (2nm
above the DWNT baseline) together with a rather uniform height
distribution (1nm above the baseline) corresponding to BSA and
PL-PEG, respectively. Although the separation of DWNTs worked
properly with either BSA or PL-PEG, the joint bi-functionalization
with both BSA and PL-PEG resulted in the most efficient
debundling and separation of DWNTs, as judged from the long-
term stability in solution and from topographical AFM images.
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Fig. 5. Specific binding of streptavidin to biotin-BSA-functionalized DWNTs. (a) Overview scan showing separated and individual nanotubes. (b) and (c) Small scan size
images and corresponding cross-section profiles. Arrows in the images mark positions where the cross-section profiles were acquired.
3.2. Specific binding of functionalized DWNTs
For testing specific binding of biomolecules to functionalized
DWNTs we used biotinylated BSA for functionalization of DWNTs
(biotin-BSA DWNTs) and subsequent exposure to a solution of
streptavidin. After filtering and washing of the streptavidin
containing suspension of biotin-BSA DWNTs, a droplet of the
dispersion was placed on mica and allowed to dry. Fig. 5 shows
topographical images with dot-like features decorating most of
the DWNTs over the entire length, indicating dense coating with
molecules. The corresponding height profile analysis (Fig. 5b and
c) showed a peak height of 3–4nm above the DWNT baseline
(with 1–2nm height of biotinylated BSA alone), indicating that
streptavidin had covered most of the biotin BSA functionalized
nanotube surface.
For specific and tight immobilization of DWNTs we prepared
a dense layer of avidin with subsequent incubation of biotin-
BSA DWNTs in buffer solution for 20min. The sample was
rigorously washed to remove loosely bound DWNTs. Fig. 6 shows
topographical images of biotin-BSA DWNTs on a dense layer of
avidin. The intactness of the avidin layer was proven by scratching
experiments resulting in a layer height of 4nm (Fig. 6b). Small
scan size images and corresponding cross-section profiles (Fig. 6b
and c) again show that the entire DWNTs were covered by bright
dots representing biotin-BSA adsorbed to the nanotubes. Due to
the strong and specific interaction between biotin-BSA DWNTs
and the mica-bound avidin layer, the nanotubes were easily
imaged in liquid conditions without any tip-induced movements.
4. Conclusion
We have established simple functionalization procedures that
provide stable aqueous suspensions of debundled and individual
DWNTs using BSA, PL-PEG or a combination thereof. AFM
topographical imaging was used for a simple and direct assess-
ment of bundling and aggregation of DWNTs, revealing well
dispersed and separated DWNTs after proper functionalization.
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Fig. 6. Specific immobilization of biotin-BSA-functionalized DWNTs to a dense layer of avidin on mica. (a) Overview image of several biotin-BSA DWNTs bound to the avidin
layer. (b) A rectangular hole was scratched into the avidin layer and imaged subsequently. From the cross-section profile the layer height was determined to be 4nm. (c)
and (d) Small scan size images and cross-section profiles of single biotin-BSA DWNTs specifically bound to the avidin layer.
Biotin-BSA-functionalized DWNTs were shown to specifically bind
streptavidin, moreover biotin-BSA DWNTs could be specifically
and tightly immobilized to a dense layer of mica-bound avidin. In
conclusion, we have demonstrated a successful non-covalent
functionalization scheme to modify DWNTs for specific recogni-
tion and binding of biomolecules, which may prove to be useful
for future use of CNTs in biological applications.
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